Singapore Business Review on MSN7 天
Tianjin Pharma posts 11 % net profit rise in Q3 2024
The group’s Chinese medicine segment primarily drove revenue, which contributed $807.8m. Tianjin Pharmaceutical Da Ren Tang ...
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 438,466.47 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical ...
Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.
Enticed by a reward of $1 million, a former police officer helped a foreign scam syndicate use Singapore as a conduit to ...
Net profit before taxes saw a 9.8% year-on-year (YoY) increase at $41.1m (AED151m) whilst the group’s revenue climbed 14% YoY in Q3, reaching $353.9m (AED1.3b).
Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue ...
With greater digital engagement and opportunities available as the world emerges from the COVID-19 pandemic, putting data to use is critical for healthcare and the pharmaceutical industry.
IPC Indice de Precios Y Cotizaciones 50,831.51-51.03-0.10% ...
German online retailer Zalando, known for its fashion and lifestyle products, announced a third-quarter net income of €44.3 ...
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.